University: London School of Hygiene and Tropical Medicine
Department: Collaborative Centre for Economics of Infectious Disease
Location: London, United Kingdom

There are a number of short courses available at LSH&TM, some directly relevant to the work of CCEID. These include: health economics and financial management

For more details on the program, please visit:
http://www.lshtm.ac.uk/hsru/cceid/index.html
http://www.lshtm.ac.uk

Organization: Institute for Health Economics, Sweden
Location: Lund, Sweden

Since 1990, IHE has been conducting seminars on health economics for Sweden's formulary committees. At first these seminars were commissioned by Apoteket AB (the National Corporation of Swedish Pharmacies); later the Federation of County Councils took over this function. The chief purpose of these seminars has been to improve participants ability to evaluate health-economic information - contained in, for example, published studies - by imparting fundamental knowledge to them. The seminars have been arranged as 24-hour residential courses (lunch to lunch) comprising the following elements: health-economic methods and examples; real-life cases with a bearing on health-economic evaluation in various therapeutic areas; economic connection with a decentralisation of responsibility for costs; and current changes in the pharmaceutical field.

From 2000 onwards, the Federation of County Councils no longer finances IHE's participation in these seminars, claiming that the committees now possess enough funds to pay for this activity themselves. IHE feels that it is essential for the committee's health-economic knowledge to be kept up to date and hence offers continued education based on the committee's own financial means, as well as on its wishes with regard to seminar form, content, target groups, etc. IHE is able to supply practical experience of cases covering particular areas (for instance new therapies such Plavix, Risperdal/Zyprexa, Cox 2- inhibitors) or constituting themes (for example cancer/diabetes and health economics); health-economic methods and examples as independent issues or integrated in various real-life cases; and experiences with generic substitution, economic control, and decision-making support when responsibility for the costs of drugs has been decentralised.

For more details about the program, please visit:
http://www.ihe.se/english/commissioned.htm
http://www.ihe.se

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: June 7 - July 2, 2004

The course is designed to prepare a non-economist to apply microeconomic theories to health systems. The topic will include theory of consumer or petients behaviour and theory of producer or health care provider, health care markets, uncertainty and health insurance.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: July 5 - July 30, 2004

This course is also designed for a non-economist to understand national economic system, of which health is becoming a major part. The course will cover the major macroeconomic tools and indices that will have impact on health or can be affected by health.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: August 2 - August 27, 2004

This course aims at enabling participants to analyse recent efforts of developing countries to finance and organise health care. The practical objective is to apply methods of economic and policy analysis to health care financing in the context of socioeconomic development.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: August 30 - September 24, 2004

The course focuses on the statistical tools necessary for the analysis of the health care system from the statistical or survey data. More emphasis will be put on empirical applications using microcomputer. The course will cover from simple regression analysis to time series data analysis.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: October 4 - October 29, 2004

This course aims at exploring the nature, purpose and limitations of economic analysis and evaluation; public and private perspectives; measurement and valuation; and analysis of costs, performance and effectiveness; evaluation of cost-effectiveness, inequality and equity.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: November 1 - November 26, 2004

This course deals with techniques, issues and approaches to health care planning in the context of limited resources, at national and district levels. Participants will be required to identity information necessary for health care planning and policy making. Particular issues, such as efficiency and equity, will be addressed.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

Department: Center for Health Economics
Location: Bangkok, Thailand
Date: November 29 - December 24, 2004

This course is directed to the analysis and decision making in health care organisations in the private and public sectors, and to examine the decision making processes required to formulate strategic plans for their development. Attention will be given to assessment of strengths and weaknesses of modelling in relation to particular types of decisions.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: Chulalongkorn University
Department: Center for Health Economics
Location: Bangkok, Thailand
Date: December 27, 2004 - January 21, 2005

This course covers the key principles of health economics research, including the roles of questions, hypotheses and theories in the research process, with critical review of research design and methodology. This will lead to the ability to prepare a research proposal, including strategies for data management, analysis and communication of results.

For more details about the program, please visit:
http://www.econ.chula.ac.th/research/chealth/index.htm

University: University of Arizona, College of Pharmacy
Department: Center for Health Outcomes and PharmacoEconomic Research
Location: Tuscon, AZ, USA Dates: September 27-30, 2004

The University of Arizona's Center for Health Outcomes and PharmacoEconomic Research is teaching the tools of pharmacoeconomics and health outcomes assessment to professionals whose job responsibilities include the application or interpretation of pharmacoeconomic information. A 4-day training program has been developed and is aimed at professionals with an entry to intermediate knowledge level. The curriculum will offer an overview of basic principles, as well as more in-depth instruction in selected areas. Participants will also learn to evaluate literature and will have the opportunity to work on a pharmacoeconomic project. Enrollment is limited to encourage interactive sessions and personalized attention. The program format will consist of lectures, case studies, workshops, and small group discussion. Participants in this training program will have the opportunity to confer with program faculty and other participants during the week in Tucson. For additional information, please contact Amy Grizzle by e-mail or by phone at 1-520-626-4721.

The Center offers customized training programs designed specifically to meet the needs of your organization. Programs may vary in length from 1/2-day to a week, and may be held in Tucson or at another location. Programs may be tailored to include:

• Small or large groups
• Varied levels of knowledge (i.e., beginning to advanced)
• Specific therapeutic areas of interest
• Specific products
• Evaluation of empirical studies (e.g., pharmaceutical economics, outcomes research, health-related quality of life, and healthcare policy)
• Simulated training sessions
• Hands-on workshops
• Project development
• Brainstorming sessions around specific issues
• In-depth examination of topics (e.g., specific statistical techniques, decision analysis, study design)
• Applied research tools and software
• Continuing pharmacy education credit

The Center has conducted specialized training programs for managed care organizations, pharmaceutical company personnel, and their clients from hospital, outpatient, and managed care settings. For additional information about customized training programs, please contact Amy Grizzle at grizzle@pharmacy.arizona.edu or 520-626-4721.

For more details about the program, please visit:
http://www.pharmacy.arizona.edu/centers/hope/hopetraining.shtml

University: Heidelberg University
Department: Department of Tropical Hygiene and Public Health
Location: Heidelberg, Germany
Date: Jun 7-18, 2004

The international postgraduate course is offered by the Department of Tropical Hygiene and Public Health at Heidelberg University in summer 2004 for the first time. Eligible are public health professionals and managers with a minimum of 2 years experience in the health sector and experience with or responsibility for health financing. Language Proficiency in English through prior study or accreditation is required.

This two weeks course will take place every year in early summer in the premisses of the Department. It is an intensive course and requires daily attendance from 09.00 to 17.00. After successful completion of the course, participants should be able to:

• Describe the basic tools used in development and assessment of financing mechanisms and critically analyze the advantages and weaknesses of these tools
• Critically analyze the roles of the public and private sector in health financing in different context
• Compare and analyze the basic features of health financing mechanisms in developing countries and in developed countries
• Design a scheme of health financing based on current theories and case study examples

The course includes the following topics:

• Options for the financing of health services
• Evaluation tools for financing of health services
• Social health insurance: Case studies from Germany, Thailand
• Technical aspects of social insurance in other European countries
• Field trip: visits of different players in the German health insurance system
• Traditional risk sharing schemes in West Africa: classification, tasks and functions
• Community based insurance (CBI): rationale, concepts and implementation
• CBI case: CBI study in Burkina Faso
• From CBI to universal coverage: re-insurance

For more details about the program please visit
the list of Postgraduate Short Courses on the website

University: Chulalongkorn University
Department: Centre for Health Economics
Location: Bangkok, Thailand
Dates: 14-18 June 2004

Economic issues related to the health sector have been gaining much attention in Thailand and Asian countries. This increasing attention to health economics in the region is due to the recent implementations of financial and structural reforms in health care sectors in this region. The challenge of providing quality and comprehensive health care to a growing population has become increasingly complex. At the same time, in recent years, there have been much medical breakthroughs and innovation, specifically in the area of pharmacological treatments. These more expensive, new treatments put further pressure on health care budgets but bring about improvements in quality of life and health status of the population. Since governments are responsible to provide supply of high-quality drugs within tight budgets, pharmaceutical companies are thus required to provide evidence of value for money for new drugs. This one-week course is an introductory course to address these important needs and to provide the necessary tools for medical personnel, policy makers, pharmaceutical executives and others working in medical or related fields.

Course Title: An Introduction to Pharmacoeconomics

Duration of the course: 1 week in June 2004

Target audience of the course: Personnel from pharmaceutical companies or government agencies who are working in the area of health care and pharmaceuticals. It primarily targets the Thai although the course will be run both in English and Thai.

Objective:

To help participants acquire a basic understanding of the concepts and practice of pharmacoeconomics. Specifically:

1. To introduce participants to basic principles of economics and its applications in the health sector, with a focus on pharmaceuticals.
2. To introduce participants to a set of analytical tools of economic evaluations of drug/health care programs.
3. To increase the knowledge of pharmaceutical regulations, pricing policy and other economic related topics.

The course will cover the following topics:

• Introduction to economic concepts: supply, demand, efficiency, equity, health policy etc.
• Basics of market and health care markets: market failures, health insurance, and pharmaceuticals markets.
• Economic evaluation for decision making : cost-effectiveness analysis, cost-utility analysis, cost-benefit analysis.
• Measuring and assigning direct and indirect costs to a health care programme
• Economics issues and pharmaceutical regulations

Teaching style:

Teaching will include core sessions with lectures to cover basic theory, and practical session involving analyzing real-world scenarios and discussions in small groups.

Lecturers:

• Dr. Siripen Supakankunti, Faculty of Economics, Chulalongkorn University
• Dr. Sauwakon Ratanawijitrasin, Faculty of Pharmaceutical Sciences, Chulalongkorn University
• Dr. Davina Ling, Faculty of Economics, California State University, Fullerton Expert from MOPH, GPO

Place: The course will be held at the Faculty of Economics, Chulalongkorn University. Chulalongkorn University is close to BTS Siam station and it offers a bus service to the station.

Facilities: The facilities of the university, which can be accessed by the participants, include large lecture rooms with standard presentation equipments such as TV, OHP, LCD, and a computer room.

Course Fee: 24,000 Bahts for June 2004 including all materials, lunch and break.

Note: In January 2005, one week advanced course will be offered.

Location: Boston, MA, USA
Dates: 16-18 August 2004

Clinical, Pharmaceutical, and Health Care Professionals... Discover the latest research methods for evaluating the impact of health care services and products on quality of life, patient satisfaction, and costs of care.

I definitely would recommend this program to my colleagues! The faculty taught difficult topics well so that even clinicians can grasp easily. The program exceeded my expectations to the point where I am seriously considering more training.

David Ling, MD
Hospitalist, Division of General Medicine
Baystate Medical Center

For more information or to register go to Harvard

Location: York, United Kingdom
Dates: 10-11 Jan 2005

An Introduction to Measuring Efficiency in Public Sector Organisations: analytical techniques and policy

Workshop to be held at the Centre for Health Economics, University of York, 10-11 January 2005

Registration Deadline: 17 December 2004

Workshop Presenters: Rowena Jacobs, Peter C Smith and Andrew Street

Overview: This two-day workshop will provide an introduction to the use of techniques for measuring the relative efficiency of public sector organisations. The two measurement tools concentrated on will be Stochastic Frontier Analysis (SFA) and Data Envelopment Analysis (DEA). Areas to be covered include:

• the context and purpose of productivity and efficiency measurement
• the economic theories underpinning efficiency measurement techniques
• how to conduct analysis
• the similarities and differences between techniques and
• the interpretation and application of results to support policy objectives

The workshop will be suitable for researchers, analysts in central and local government, and PhD students.

Full details

Location: Lausanne, Switzerland
Dates: 22-26 Nov 2004 (Part 1), 24-28 Jan 2005 (Part 2)

Faculty
Prof. Pierre-Yves Geoffard (University of Lausanne)
Prof. Michel Mougeot (University of Lausanne)
Prof. Peter Zweifel (University of Zurich)

Presentation: This course offers a comprehensive view of the economics of health systems (i.e. health care provision and its financing). The analytical framework will provide an integrated set-up to analyze regulation issues, both on the demand and the supply side.

Objectives: Participants will be familiar with the main tools of micro-economic analysis of health systems, with an emphasis on informational issues. Models of asymmetric information will be studied in details, as well as their applicability to the study of health insurance and health care production.

The course is part of the a series of five modules offered as the International PhD Programme in Health Economics and Policy intended for PhD students who are wishing to enhance their specific knowledge and sharpen their capabilities in the field of health economics and policy.

Full Details

Location: Boston, Massachusetts
Dates: June 13 - 16, 2005

Advanced, hands-on training program taught by the faculty of the Program on Economic Evaluation of Medical Technology

Learn to develop and design economic evaluations in clinical trials and modeling studies specifically suited to your organization’s purpose

Topics include:

• Microsimulation Modeling
• Markov Models in DATA
• Uncertainty Analysis
• Costing Alongside Clinical Trials
• The AMCP Format Process
• HRQOL and Utility Analysis

Special Program Features:

• Hands-on computer lab using decision analysis software
• Breakout groups designing cost-effectiveness studies

Who Should Attend Outcomes analysts and economists in the pharmaceutical and medical device industries, and others in academia and government, who conduct or monitor cost-effectiveness analyses of medical technologies, including:

• industry pharmacoeconomists
• managed care outcomes analysts
• government policy analysts
• outcomes researchers and managers
• diagnostic technology assessors and developers
• clinical researchers concerned with economic outcomes
• research and development planners

This is an advanced-level program on methods for performing cost-effectiveness analysis of pharmaceutical and medical technologies. Knowledge of cost-effectiveness analysis at the level of Drummond et al. (Methods for the Economic Evaluation of Health Care Programmes) and Gold et al. (Cost-Effectiveness in Health and Medicine) will be assumed. There will be little, if any, review of basic concepts, in order to allow maximum time to address technical challenges in designing and performing cost-effectiveness analysis in real-world settings.

Program Director

Milton C. Weinstein, PhD Henry J. Kaiser Professor of Health Policy and Management Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health Director, Program on the Economic Evaluation of Medical Technology Professor of Medicine Harvard Medical School

Program Faculty

• David Cohen, MD, MS
• G. Scott Gazelle, MD, MPH, PhD
• Sue J. Goldie, MD, MPH
• Karen M. Kuntz, ScD
• Peter J. Neumann, ScD
• Lisa A. Prosser, PhD
• Jane C. Weeks, MD, MSc

For more information and to apply: http://www.hsph.harvard.edu/ccpe/programs/CEA.shtml

University: Erasmus University Rotterdam
Location: Rotterdam, The Netherlands
Dates: April 4-8, 2005

The Institute for Medical Technology Assessment will organise an advanced course in 'economic evaluation of healthcare programs' this spring. The objective of the course is to give the participants a better understanding of the key methodological issues in economic evaluation and quality of life assessment. It is intended for those who already have some knowledge of economic evaluations and are involved in initiating, undertaking, managing or interpreting economic evaluations of health care programs, diagnostic and therapeutic interventions and medicines.

The course consists of several modules, each of which will incorporate lectures, cases or computer exercises and group discussions. Furthermore each participant will receive a full documentation pack related to the teaching days and containing selected articles for further study.

The course includes a comprehensive coverage of all important issues in the methodology and practice of economic evaluation. The main design features of studies, such as costing methods, health-state measurement and preference valuation, generalisation issues and integrating economic analyses with clinical trials and modelling, will be considered in this course.

The course staff are all experts in this area from the Erasmus University Rotterdam. They are all very experienced and have extensively published on the topic on which they will lecture in the course. Please see the enclosed course programme for further details. The course fee is EUR 1950,- for the full week, or EUR 650 per day, including coffee, tea, lunch and the course dinner on Thursday. The number of participants in the course is limited to 20. The course will take place at the "Woudestein" location of the Erasmus University in Rotterdam, and will start each day at 9.30h, with some time for socialising scheduled on Monday and Thursday evening. Furthermore, it is expected that participants will work on an assignment in the evenings. Our secretary will assist you in making hotel reservations.

If you are interested in participating, please register by completing the registration form on our website (www.imta.nl, click the "news" button). If you have any further questions, you can contact our secretary Mrs. Ineke de Klerk by e-mail, or by phone +3110-4088571. After we have received your registration, you will receive a confirmation of your registration and instructions for payment.

University: University of Lausanne and Harvard Medical International
Location: University of Lausanne, Switzerland Dates: 23-27 May, 2005

A innovative executive education program offered by the University of Lausanne and Harvard Medical International to prepare participants to take a leadership role in their organizations and the health care sector.

Facutly Directors: Prof. Alberto Holly (Lausanne University), Miles Shore (Harvard University)

Program goals: This program is aimed at individuals with outstanding potential from both the private and public sectors who need to address the following questions:

• How do health care systems compare? How could they be improved?
• How can we evaluate health technology? What should be done about its rapid development?
• What can health care leaders do about rising costs? Can concern with cost be replaced by a focus on value?
• What is quality in health care? How can it be evaluated and improved?
• What are the principles underlying innovation? Can innovation improve quality, reduce costs and prevent medical error?
• How to lead change in health care?

Faculty: In addition to Professors Alberto Holly and Miles Shore, program directors, indicative faculty for the 2005 program included:

• Richard G. Frank, Professor of Health Care Policy, Harvard Medical School, Harvard University
• Panos Kanavos, Lecturer in International Health Policy, London School of Economics
• Joseph P. Newhouse, John D. McArthur Professor of Health Policy and Management, Kennedy School of Government and Harvard School of Public Health, Harvard University
• Fred Paccaud, Professor and Director, Institute for Social and Preventive Medicine, University of Lausanne
• Pierre-Yves Geoffard, Senior Research Fellow, CNRS and Visiting Professor, University of Lausanne
• Bengt Jönsson, Associate Professor, Stockholm School of Economics
• Stefan Winter, General Director and Chief Medical Officer, German Ministry for Health and Social Security
• David Blumenthal, Director, Institute for Health Policy at the Massachussets General Hospital, and Professor, Harvard Medical School
• Martin McKneally, Professor, University of Toronto

Participants' profile: They are professionals from both the private and public sectors: insurance companies, pharmaceutical companies, academic institutions, health authorities, medical doctors, pharmacists

For more information
Isabelle Chappuis
Institute of Health Economics and Management
e-mail
Tel: 41-21-314-4986
Fax: 41-21-314-6911

Location: Barcelona, Spain and Berkeley, CA, USA
Dates: July 15-22, 2005 (Barcelona) and January 6-13, 2006 (Berkeley)

Faculty Directors: Richard Scheffler PhD, Guillem Lopez-Casasnovas PhD, and Pere Ibern, PhD; Administrative Director: Meg A. Kellogg

Objectives: Participants will substantially advance their knowledge of workable solutions, innovations, and how to request and interpret policy analyses. They will also make important contacts with other prominent health care leaders from around the world-both speakers and fellow participants.

Presentation: A 14-day earned certificate program in which renowned senior faculty and policy leaders from key international and national organizations interact with high-level participants re: evidenced- based solutions to key policy and management issues. Participants grapple in a practical manner with the issues and options that have been converging internationally.

Faculty: Guest speakers include: Harvey Fineberg, president of the US Institute of Medicine of the National Academies of Sciences, Leonard Schaeffer, CEO of Wellpoint, Bruce Bodaken, CEO of Blue Shield of California, two-term governor of Oregon Dr. John Kitzhaber, Molly Coye of the Health Technology Center, Richard Feachem, Executive Director of the Global Fund on AIDS, and executives from Kaiser Permanente, the United Kingdom's National Health Service, WHO, the World Bank,and the European Union. Top faculty from UC Berkeley, UCSF and six Universities in Europe are also presenters and participants in the stimulating discussions.

Sample issues: evidenced-based leadership and management, how to assure quality, public vs. private health insurance mix, innovations in payer and health delivery connections, pharmaceutical innovation, pricing and regulation, defining benefit packages including explicit priority setting/rationing, making use of the new consumerism, lessons learned from managed care techniques, dealing with aging, long term care, mental health, and technology changes and future health care predictions to prepare for.

Who should attend: Senior executives of nations: health ministers or senior policy leaders, legislators and regulators, senior executives of organizations (e.g. World Bank, OECD, PAHO, policy research organizations) or enterprises (e.g. insurance, pharmaceutical, health care delivery, health care devices, care management)

Click for Full Details